Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
19 February 2026
| Name: | NEXT SCIENCE LIMITED (NXS) |
| ISIN: | AU0000041329 |
| Date of Listing: | 18 April 2019 |
| Date of Delisting: | 10 February 2026 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 10 February 2026.Legal Status:
ACN*: 622 382 549ABN: 47 622 382 549
Registration Date: 20 October 2017
Capital Gains Tax (CGT) Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
* ARBN if foreign entity
REGISTRY:
Automic Group
Level 5, 126 Philip Street Sydney NSW 2000
GPO Box 5193 Sydney NSW 2001
Tel : 1300 288 664 or +61 2 9698 5414
Fax : +61 2 8583 3040
RegistryWebsite RegistryEmail
delisted at entity's request under Listing Rule 17.11 | 10/02/2026 |
we understand the Company completed the sale of substantially all the assets of Next Science and its wholly-owned subsidiaries ("NXS Group") to OSARTIS GmbH, a Demetra company on 15 September 2025 and made a cash return of capital payment of $0.145 cash per share on 10 February 2026. (NXS is engaging with the ATO to confirm the income tax consequences of the Capital Return) | 10/02/2026 |
The company confirms the cash return of capital payment announced on 30 January 2026 has been made on 10 February 2026. The Company has requested ASX for voluntary delisting, effective 11 February 2026, having met ASX conditions. | 09/02/2026 |
The company lodges an update of its notice of cash return of capital. | 02/02/2026 |
The company announces an amendment to its cash return of capital payment date. The new payment date is set for Tuesday, 10 February 2026. A revised Appendix 3A.4 has been released today, which retains all other details from the prior announcement made on 28 January 2026. | 30/01/2026 |
The company lodges its notice of cash return of capital. | 28/01/2026 |
The company releases the voting results of its general meeting. | 28/01/2026 |
The company lodges its quarterly activity report and appendix 4C for December 2025. | 28/01/2026 |
The company will face a suspension of its securities from quotation starting Friday, 2 January 2026, according to Listing Rule 17.3.1, following a six-month period to sell its main undertaking. ASX monitored NXS's operational sufficiency for continued quotation under Listing Rule 12.1 but determined that NXS lacks adequate operations. The suspension remains in effect until ASX is assured that NXS meets all Listing Rules requirements for reinstatement. | 02/01/2026 |
listed entity carried for record purposes only | 18/04/2019 |
delisted at entity's request under Listing Rule 17.11 | 10/02/2026 |
we understand the Company completed the sale of substantially all the assets of Next Science and its wholly-owned subsidiaries ("NXS Group") to OSARTIS GmbH, a Demetra company on 15 September 2025 and made a cash return of capital payment of $0.145 cash per share on 10 February 2026. (NXS is engaging with the ATO to confirm the income tax consequences of the Capital Return) | 10/02/2026 |
The company confirms the cash return of capital payment announced on 30 January 2026 has been made on 10 February 2026. The Company has requested ASX for voluntary delisting, effective 11 February 2026, having met ASX conditions. | 09/02/2026 |
The company lodges an update of its notice of cash return of capital. | 02/02/2026 |
The company announces an amendment to its cash return of capital payment date. The new payment date is set for Tuesday, 10 February 2026. A revised Appendix 3A.4 has been released today, which retains all other details from the prior announcement made on 28 January 2026. | 30/01/2026 |
The company lodges its notice of cash return of capital. | 28/01/2026 |
The company releases the voting results of its general meeting. | 28/01/2026 |
The company lodges its quarterly activity report and appendix 4C for December 2025. | 28/01/2026 |
The company will face a suspension of its securities from quotation starting Friday, 2 January 2026, according to Listing Rule 17.3.1, following a six-month period to sell its main undertaking. ASX monitored NXS's operational sufficiency for continued quotation under Listing Rule 12.1 but determined that NXS lacks adequate operations. The suspension remains in effect until ASX is assured that NXS meets all Listing Rules requirements for reinstatement. | 02/01/2026 |
listed entity carried for record purposes only | 18/04/2019 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 30/03/2022 | Judith Mitchell | 140,000 | $0.881 | $123,310 | |
| 24/11/2020 | Judith Mitchell | 67,362 | $1.140 | $76,793 | |
| 24/11/2020 | Bruce Hancox | 130,000 | $1.149 | $149,344 | |
| 29/10/2020 | Judith Mitchell | 188,200 | $1.150 | $216,430 | |
| 28/10/2020 | Bruce Hancox | 30,000 | $1.160 | $34,800 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Aileen Stockburger | Chairman | 18/10/2018 |
| Grant Hummel | Independent Director | 23/08/2023 |
| Katherine Ostin | Independent Director | 24/10/2023 |
| Gillian Nairn | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Harry Hall | Managing Director, CEO | 10/07/2023 | 31/12/2025 |
| Marc Zimmerman | CFO | 29/06/2023 | 31/12/2025 |
| Dan Spira | Non Exec Director | 18/04/2019 | 03/05/2024 |
| Mark Compton | Chairman | 18/10/2018 | 23/08/2023 |
| Judith Mitchell | Managing Director | 11/08/2017 | 02/08/2023 |
| Bruce Hancox | Non Exec Director | 18/04/2019 | 30/06/2023 |
| George Savvides | Chairman, Independent Director | 01/08/2018 | 05/05/2021 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2026 Investogain Pty Limited. All rights reserved.
